Gross Profit Margin (Quarterly) Chart

Historical Gross Profit Margin (Quarterly) Data

View and export this data back to 1998. Start Trial.
Date Value
June 30, 2026 57.64%
March 31, 2026 60.34%
December 31, 2025 58.20%
September 30, 2025 59.87%
June 30, 2025 66.63%
March 31, 2025 61.42%
December 31, 2024 59.50%
September 30, 2024 58.66%
June 30, 2024 59.69%
March 31, 2024 60.16%
December 31, 2023 59.00%
September 30, 2023 58.23%
June 30, 2023 56.46%
March 31, 2023 61.56%
December 31, 2022 59.24%
September 30, 2022 59.82%
June 30, 2022 60.91%
March 31, 2022 61.20%
December 31, 2021 60.67%
September 30, 2021 60.30%
June 30, 2021 60.92%
March 31, 2021 62.02%
December 31, 2020 58.49%
September 30, 2020 54.83%
June 30, 2020 53.85%
Date Value
March 31, 2020 56.25%
December 31, 2019 55.53%
September 30, 2019 55.77%
June 30, 2019 55.88%
March 31, 2019 55.80%
December 31, 2018 55.03%
September 30, 2018 55.44%
June 30, 2018 56.56%
March 31, 2018 56.30%
December 31, 2017 55.83%
September 30, 2017 56.02%
June 30, 2017 55.50%
March 31, 2017 55.50%
December 31, 2016 54.53%
September 30, 2016 55.32%
June 30, 2016 56.14%
March 31, 2016 55.23%
December 31, 2015 51.20%
September 30, 2015 52.49%
June 30, 2015 53.84%
March 31, 2015 53.35%
December 31, 2014 51.76%
September 30, 2014 52.68%
June 30, 2014 52.79%
March 31, 2014 52.61%

Gross Profit Margin Definition

Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.

Read full definition.

Gross Profit Margin (Quarterly) Range, Past 5 Years

View Gross Profit Margin (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Gross Profit Margin (Quarterly) Benchmarks

View Gross Profit Margin (Quarterly) Benchmarks
Start Trial
Thermo Fisher Scientific, Inc. 40.94%
Agilent Technologies, Inc. 55.48%
Illumina, Inc. 66.49%
Revvity, Inc. 50.26%
Bio-Rad Laboratories, Inc. 53.12%